Extraction form for project: Interventional Treatments for Acute and Chronic Pain: Systematic Review
Design Details
1. Trial Intervention
Input which intervention is being studied
2. Trial Name
3. Setting
Country
4. Study Design
5. Mean Age (Years)
Input the mean age for the entire sample
6. Percent Female
Input the whole number here for the entire study sample - no need to add %
7. Number Randomized
8. Pain Duration Measure (Mean, Median)
9. Pain Duration (Weeks)
10. Duration of Followup (Months)
Arms
Arm Name | Arm Description |
---|---|
Botulinum toxin type A piriformis injection | 300 units 3 ml intramuscular injection to 4 piriformis muscle sites (the most medial injection was made just lateral to the greater sciatic foramen along the line linking its midpoint to the greater trochanter) including the myoneural junctions of the S1 to S2 nerve fibers that innervate the piriformis muscle; placement with electromyographic guidance |
Placebo injection | 3 ml saline injection as above |
Arm Details
N/A
Sample Characteristics
N/A
Outcomes
- All Participants
- 4 (weeks)
- 12 (weeks)
Type | Domain | Specific measurement (i.e., tool/definition/specific outcome) | Populations | Timepoints |
---|---|---|---|---|
Continuous | Pain | Mean (SD) change from baseline, scale unclear |
Outcome Details
N/A
Risk of Bias Assessment
1. What kind of study is this?
2. Randomization adequate?
3. Allocation concealment adequate?
4. Groups similar at baseline?
5. Outcome assessors masked?
6. Care provider masked?
7. Patient masked?
8. Acceptable levels of overall attrition and between-group differences in attrition?
9. Intention-to-Treat (ITT) analysis?
10. Avoidance of selective outcomes reporting
11. Quality rating
Results
Continuous
Pain (Mean (SD) change from baseline, scale unclear)
Descriptive Statistics | Between Arm Comparisons | ||||
---|---|---|---|---|---|
Botulinum toxin type A piriformis injection | Placebo injection | ||||
4 (weeks) | |||||
Mean | Mean Difference (MD) | ||||
SD | 95% CI low (MD) | ||||
95% CI high (MD) | |||||
SD (MD) | |||||
p value (MD) | |||||
12 (weeks) | |||||
Mean | Mean Difference (MD) | ||||
SD | 95% CI low (MD) | ||||
95% CI high (MD) | |||||
SD (MD) | |||||
p value (MD) | |||||
Within Arm Comparisons | Net Comparisons | ||||
Botulinum toxin type A piriformis injection | Placebo injection |